Rain Therapeutics (NASDAQ: RAIN)
Rain Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rain Therapeutics Company Info
Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA.
Valuation
Earnings Transcripts
Rain Therapeutics Inc. (RAIN) Q2 2022 Earnings Call Transcript
RAIN earnings call for the period ending June 30, 2022.
Motley Fool Transcribing | Aug 6, 2022
Rain Therapeutics Inc. (RAIN) Q4 2021 Earnings Call Transcript
RAIN earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Mar 3, 2022
Rain Therapeutics Inc. (RAIN) Q3 2021 Earnings Call Transcript
RAIN earnings call for the period ending September 30, 2021.
Motley Fool Transcribing | Nov 11, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.